Annual Total Long Term Liabilities
$3.77 M
-$468.00 K-11.05%
December 31, 2023
Summary
- As of March 10, 2025, ACRV annual total long term liabilities is $3.77 million, with the most recent change of -$468.00 thousand (-11.05%) on December 31, 2023.
- During the last 3 years, ACRV annual total long term liabilities has fallen by -$6.22 million (-62.27%).
- ACRV annual total long term liabilities is now -97.05% below its all-time high of $127.48 million, reached on December 31, 2021.
Performance
ACRV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.97 M
-$270.00 K-8.33%
September 30, 2024
Summary
- As of March 10, 2025, ACRV quarterly total long term liabilities is $2.97 million, with the most recent change of -$270.00 thousand (-8.33%) on September 30, 2024.
- Over the past year, ACRV quarterly long term liabilities has stayed the same.
- ACRV quarterly long term liabilities is now -97.67% below its all-time high of $127.48 million, reached on December 1, 2021.
Performance
ACRV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ACRV Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.1% | 0.0% |
| 3 y3 years | -62.3% | 0.0% |
| 5 y5 years | -62.3% | 0.0% |
ACRV Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.0% | at low | -97.7% | at low |
| 5 y | 5-year | -97.0% | at low | -97.7% | at low |
| alltime | all time | -97.0% | at low | -97.7% | at low |
Acrivon Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.97 M(-8.3%) |
| Jun 2024 | - | $3.24 M(-7.4%) |
| Mar 2024 | - | $3.50 M(-7.1%) |
| Dec 2023 | $3.77 M | $3.77 M(+3.4%) |
| Sep 2023 | - | $3.64 M(-5.3%) |
| Jun 2023 | - | $3.85 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.05 M(-4.5%) |
| Dec 2022 | $4.24 M(-96.7%) | $4.24 M(-96.7%) |
| Sep 2022 | - | $126.94 M(-0.1%) |
| Jun 2022 | - | $127.12 M(-0.3%) |
| Dec 2021 | $127.48 M(+1176.7%) | - |
| Dec 2021 | - | $127.48 M |
| Dec 2020 | $9.98 M | - |
FAQ
- What is Acrivon Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual total long term liabilities year-on-year change?
- What is Acrivon Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly long term liabilities year-on-year change?
What is Acrivon Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ACRV is $3.77 M
What is the all time high annual total long term liabilities for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual total long term liabilities is $127.48 M
What is Acrivon Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ACRV annual total long term liabilities has changed by -$468.00 K (-11.05%)
What is Acrivon Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ACRV is $2.97 M
What is the all time high quarterly long term liabilities for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly total long term liabilities is $127.48 M
What is Acrivon Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ACRV quarterly total long term liabilities has changed by $0.00 (0.00%)